Product NDC: | 39822-0412 |
Proprietary Name: | Tobramycin |
Non Proprietary Name: | Tobramycin |
Active Ingredient(s): | 1.2 g/30mL & nbsp; Tobramycin |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 39822-0412 |
Labeler Name: | X-GEN Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065013 |
Marketing Category: | ANDA |
Start Marketing Date: | 20010817 |
Package NDC: | 39822-0412-6 |
Package Description: | 6 VIAL in 1 CARTON (39822-0412-6) > 30 mL in 1 VIAL |
NDC Code | 39822-0412-6 |
Proprietary Name | Tobramycin |
Package Description | 6 VIAL in 1 CARTON (39822-0412-6) > 30 mL in 1 VIAL |
Product NDC | 39822-0412 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Tobramycin |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20010817 |
Marketing Category Name | ANDA |
Labeler Name | X-GEN Pharmaceuticals, Inc. |
Substance Name | TOBRAMYCIN SULFATE |
Strength Number | 1.2 |
Strength Unit | g/30mL |
Pharmaceutical Classes | Aminoglycoside Antibacterial [EPC],Aminoglycosides [Chemical/Ingredient] |